Hypodermic Syringes And Needles Market Report 2026

Hypodermic Syringes And Needles Market Overview

• Hypodermic Syringes And Needles market size has reached to $7.13 billion in 2025 • Expected to grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Rise In Surgical Procedures To Drive Market Growth • Market Trend: Advanced Pre-Fillable Syringe Systems Reshaping The Market • North America was the largest region in 2025.

What Is Covered Under Hypodermic Syringes And Needles Market?

Hypodermic syringes and needles are medical devices used to inject or withdraw bodily fluids or medications. The syringe consists of a barrel, a plunger, and a tip or hub where the needle is attached. The main types of hypodermic syringes and needles are syringes and needles. Syringes are cylindrical devices with a plunger to inject or withdraw bodily fluids. Hypodermic syringes are used for various medical purposes, including blood collection through venipuncture. The hypodermic syringes and needles are available disposable and re-usable models that are applied in blood collection, drug delivery, vaccination, insulin administration, and other applications in hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.

What Is The Hypodermic Syringes And Needles Market Growth Forecast?

The hypodermic syringes and needles market size is expected to see strong growth in the next few years. It will grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing demand for mass immunization campaigns, rising adoption of safety needles, expansion of home healthcare injection use, growing focus on needle-stick injury prevention, increasing investments in medical consumables manufacturing. Major trends in the forecast period include increasing adoption of safety-engineered syringes and needles, rising demand for disposable injection devices, growing focus on infection prevention solutions, expansion of prefilled and specialty syringe usage, enhanced emphasis on regulatory compliance.

Global Hypodermic Syringes And Needles Market Segmentation

1) By Type: Syringes, Needles 2) By Usability: Disposable, Safety-Engineered Syringes and Needles 3) By Application: Blood Collection, Drug Delivery, Vaccination, Insulin Administration, Other Applications 4) By End-Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End-Uses Subsegments: 1) By Syringes: Disposable Syringes, Safety Syringes 2) By Needles: Standard Needles, Safety Needles, Specialty Needles

What Is The Driver Of The Hypodermic Syringes And Needles Market?

The increase in surgical procedures is expected to propel the growth of the hypodermic syringes and needles market going forward. Surgical procedures refer to medical interventions or operations performed by qualified surgeons or medical professionals to treat, repair, remove, or diagnose a medical condition. Surgical procedures often involve the administration of medications, anesthetics, or other substances through injections. Hypodermic syringes and needles are fundamental tools for delivering precise and controlled doses of these substances. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increased number of surgical procedures is driving the growth of the hypodermic syringes and needles industry.

Key Players In The Global Hypodermic Syringes And Needles Market

Major companies operating in the hypodermic syringes and needles market are Becton Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., Vygon S.A., Codan Medizinische Geräte GmbH & Co. KG, Vitrex Medical A/S, EXELINT International Co., Helapet Ltd., DeRoyal Industries Inc., Teleflex Incorporated, Gerresheimer AG, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Weihai Weigao Group Medical Polymer Co. Ltd., Retractable Technologies Inc., Sarstedt AG & Co. KG, Jiangsu Zhengkang Medical Apparatus Co. Ltd., JECT Corporation

Global Hypodermic Syringes And Needles Market Trends and Insights

Major companies operating in the hypodermic syringes and needles market are developing pre-fillable glass syringe systems to gain a competitive edge in the market. A pre-fillable syringe system is a medical device designed for the storage and administration of pharmaceuticals, vaccines, or other injectable substances. For instance, in September 2023, Nipro Corporation, a Japan-based medical device company, launched D2F Pre-fillable Glass Syringe System – Silicone Oil-Free, addressing a critical need in the pharmaceutical industry for drug products highly sensitive to silicone oil. The D2F system provides a silicone oil-free solution with key quality attributes, including smooth plunger movement performance, very low particle levels, and excellent drug-container compatibility. The D2F Pre-fillable Glass Syringe System aims to meet the growing demand for injection systems that ensure optimal performance and minimize the risk of interaction-related issues in the delivery of biotech drugs and other sensitive pharmaceuticals.

What Are Latest Mergers And Acquisitions In The Hypodermic Syringes And Needles Market?

In September 2023, Sharps Technology, Inc., a US-based medical-products and manufacturing company, acquired the InjectEZ from Nephron Pharmaceuticals for an undisclosed amount. Through this acquisition, Sharps aims to accelerate the commercialization of next-generation copolymer prefillable syringes in the U.S. market and fulfill multi-year purchase commitments from Nephron and other customers. InjectEZ LLC is a US-based company that provides a prefillable copolymer syringes.

Regional Outlook

North America was the largest region in the hypodermic syringes and needles market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hypodermic Syringes And Needles Market?

The hypodermic syringes and needles market revenues include earned by entities by vacutainer and other consumables, such as pistons, sharps, and sterile containers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.